#Pharmaceutical Industry
Explore articles tagged with Pharmaceutical Industry
HRV Pharma and Metrochem Strategic CDMO Alliance for High-Value NCE-1 APIs
HRV Pharma and Metrochem API Pvt. Ltd. have formed a multi-year CDMO alliance to accelerate high-value NCE-1 API development, combining Virtual Pharma innovation with world-class GMP chemistry
AI Is Redefining Pharma Forecasting and Eliminating the Compliance Trade-Off
Pharmaceutical Commerce features HRV Pharma on how AI-validated digital backbones speed regulatory reviews, improve supplier onboarding, and make forecasting more reliable.
Can AI Make Pharma Supply Chains Truly Unbreakable?
HRV Pharma's CEO discusses how AI transforms pharmaceutical supply chains from reactive systems to anticipatory networks, ensuring continuous medicine availability through predictive intelligence.
Rethinking Pharma Supply Chains: Building Resilience With Digital Intelligence
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
Building Resilient Pharmaceutical Supply Chains in an Era of Disruption
HRV Pharma's MD & CEO Hari Kiran Chereddi discusses strategic approaches to pharmaceutical supply chain resilience, highlighting multi-partner networks and AI-native operations for industry transformation.
From Pharmacy to Intelligent Pharmacy: AI's Role in India's Pharma Evolution
HRV Pharma's CEO Hari Kiran Chereddi discusses how AI is transforming India from the traditional "pharmacy of the world" into the "intelligent pharmacy of the world," revolutionizing drug discovery, regulatory processes, and supply chain management
From Volume to Value: India's Strategic API Leadership Evolution
HRV Global's Managing Director Hari Kiran Chereddi discusses India's transformation from volume-driven API supplier to value-oriented strategic partner, highlighting virtual pharma models and AI-driven operations.
US Tariffs Threaten Indian Pharma Exports-Urgent Need for Diversification and Policy Support
Our leadership analyzes impact of US 50% tariffs on Indian pharmaceutical exports, highlighting challenges for SMEs and strategic responses including market diversification.